Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 931 AL 945

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid]

Ono N, Maruyama G, Akaiwa Y, Nakamura T, Tamai C, Sone J, Miyamoto T.

Rinsho Shinkeigaku. 2025 Dec 19;65(12):912-915. doi: 10.5692/clinicalneurol.cn-002153. Epub 2025 Nov 22.

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases

Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F.

Acta Neurol Belg. 2025 Jun;125(3):691-698. doi: 10.1007/s13760-025-02759-2. Epub 2025 Mar 11.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

High circulating adropin levels predict long-term blood pressure variability in old adults: evidence from the Multidomain Alzheimer Prevention Trial

Aggarwal G, Salas J, Vellas B, Nguyen AD, Butler AA; MAPT/IHU HealthAge Open Science Group.

Am J Physiol Heart Circ Physiol. 2025 Dec 1;329(6):H1684-H1692. doi: 10.1152/ajpheart.00763.2025. Epub 2025 Nov 18.

Comparison of multi-miRNA models from donor-matched plasma and cerebrospinal fluid as candidate biomarkers for Alzheimer's disease prediction

Sandau US, Wiedrick JT, McFarland TJ, Chen S, Quinn JF, Saugstad JA.

Sci Rep. 2025 Dec 24;16(1):3207. doi: 10.1038/s41598-025-33589-0.

Dysregulation of the molecular clock by blood-borne factors in Alzheimer's disease patients

Zhao C, Li T, Hao S, Zhao L, Han Y, Cai Y.

J Neurol. 2025 Jan 15;272(2):121. doi: 10.1007/s00415-024-12824-0.

Proper Name Recall as an Early Indicator of Preclinical Alzheimer Disease Pathology

Mueller KD, Soldan A, Langhough R, Bruno D, Jauregi-Zinkunegi A, Basche K, Hale MR, He D, Moghekar A, Hermann B, Albert M, Pettigrew C.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):269-276. doi: 10.1097/WAD.0000000000000695. Epub 2025 Nov 10.

Early axonal degeneration linked to clinical decline in Alzheimer's disease progression revealed with diffusion MRI

Gong Z, Laporte JP, Guo AY, Bilgel M, Bae J, Fox NY, de Rouen A, Zhang N, Taranath A, de Cabo R, Egan JM, Ferrucci L, Bouhrara M; Alzheimer’s Disease Neuroimaging Initiative.

J Clin Invest. 2025 Nov 27;136(3):e196638. doi: 10.1172/JCI196638. eCollection 2026 Feb 2.

Antiamyloid Therapy and Cerebral Blood Flow Changes on MRI: A Potential Longitudinal Biomarker of Treatment Response?

Ricaurte-Fajardo A, Ivanidze J, Zhang D, Mahmud M, Yasen W, Ravdin L, Pahlajani S, Leon M, Nordvig AS, Chiang GC.

AJNR Am J Neuroradiol. 2025 Jul 1;46(7):1439-1445. doi: 10.3174/ajnr.A8654.

The Eye as a Window to Brain Health: Can Retinal Imaging and AI Modeling Predict Alzheimer's Disease?

Awodiya E.

Brain Behav. 2025 Oct;15(10):e70890. doi: 10.1002/brb3.70890.

Cerebellar atrophy in biologically confirmed Alzheimer's disease: Associations with amyloidopathy measured by cerebrospinal fluid biomarkers

Munoz-Musat E, Le Prince G, Delmaire C, Paquet C.

J Alzheimers Dis. 2025 Dec;108(3):1204-1211. doi: 10.1177/13872877251386085. Epub 2025 Oct 17.

A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology

Liou JJ, Lou J, Flores-Aguilar L, Nakagiri J, Yong W, Hom CL, Doran EW, Totoiu MO, Lott I, Mapstone M, Keator DB, Brickman AM, Wright ST, Nelson B, Lai F, Xicota L, Dang LT, Li J, Santini T, Mettenburg JM, Ikonomovic MD, Kofler J, Ibrahim T, Head E; Alzheimer Biomarker Consortium ‐ Down Syndrome.

Alzheimers Dement. 2025 Feb;21(2):e14479. doi: 10.1002/alz.14479. Epub 2025 Jan 27.

PDE5 Inhibitors as Modulators of Alzheimer's-Associated Inflammation and Oxidative Stress: A Meta-Analytical Assessment of Preclinical Studies

Uppuluri CT, Prasad YSKV, Asadi K, Kumari TP, Pelluri R, Chakravarthi G, Nalluri BN, Gurram PC.

Mol Neurobiol. 2025 Dec 23;63(1):322. doi: 10.1007/s12035-025-05635-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias